Showing 1 - 20 results of 27 for search 'Enrico Maggi', query time: 0.06s Refine Results
  1. 1
    Medroxyprogesterone Acetate Decreases Th1, Th17, and Increases Th22 Responses via AHR Signaling Which Could Affect Susceptibility to Infections and Inflammatory Disease

    Medroxyprogesterone Acetate Decreases Th1, Th17, and Increases Th22 Responses via AHR Signaling Which Could Affect Susceptibility to Infections and Inflammatory Disease by Marie-Pierre Piccinni, Letizia Lombardelli, Federica Logiodice, Ornela Kullolli, Enrico Maggi, Enrico Maggi, Marylynn S. Barkley

    Published 2019-04-01
    Get full text
    Article
  2. 2
    Is IgE or eosinophils the key player in allergic asthma pathogenesis? Are we asking the right question?

    Is IgE or eosinophils the key player in allergic asthma pathogenesis? Are we asking the right question? by Andrea Matucci, Alessandra Vultaggio, Enrico Maggi, Ismail Kasujee

    Published 2018-06-01
    Get full text
    Article
  3. 3
    The Latest Approach of Immunotherapy with Endosomal TLR Agonists Improving NK Cell Function: An Overview

    The Latest Approach of Immunotherapy with Endosomal TLR Agonists Improving NK Cell Function: An Overview by Irene Veneziani, Claudia Alicata, Lorenzo Moretta, Enrico Maggi

    Published 2022-12-01
    Get full text
    Article
  4. 4
    T Cell Response to Infliximab in Exposed Patients: A Longitudinal Analysis

    T Cell Response to Infliximab in Exposed Patients: A Longitudinal Analysis by Sara Pratesi, Francesca Nencini, Francesca Grosso, Laura Dies, Susanna Bormioli, Daniele Cammelli, Enrico Maggi, Enrico Maggi, Andrea Matucci, Alessandra Vultaggio, ABIRISK Consortium

    Published 2019-01-01
    Get full text
    Article
  5. 5
    Group 2 Innate Lymphoid Cells: A Double-Edged Sword in Cancer?

    Group 2 Innate Lymphoid Cells: A Double-Edged Sword in Cancer? by Enrico Maggi, Irene Veneziani, Lorenzo Moretta, Lorenzo Cosmi, Francesco Annunziato

    Published 2020-11-01
    Get full text
    Article
  6. 6
    Strategies Targeting Type 2 Inflammation: From Monoclonal Antibodies to JAK-Inhibitors

    Strategies Targeting Type 2 Inflammation: From Monoclonal Antibodies to JAK-Inhibitors by Andrea Matucci, Emanuele Vivarelli, Francesca Nencini, Enrico Maggi, Alessandra Vultaggio

    Published 2021-10-01
    Get full text
    Article
  7. 7
    Mechanisms of Drug Desensitization: Not Only Mast Cells

    Mechanisms of Drug Desensitization: Not Only Mast Cells by Alessandra Vultaggio, Andrea Matucci, Francesca Nencini, Susanna Bormioli, Emanuele Vivarelli, Enrico Maggi

    Published 2020-12-01
    Get full text
    Article
  8. 8
    How the Immune System Responds to Allergy Immunotherapy

    How the Immune System Responds to Allergy Immunotherapy by Irene Veneziani, Nadine Landolina, Biancamaria Ricci, Oliviero Rossi, Lorenzo Moretta, Enrico Maggi

    Published 2022-11-01
    Get full text
    Article
  9. 9
    How to Prevent and Mitigate Hypersensitivity Reactions to Biologicals Induced by Anti-Drug Antibodies?

    How to Prevent and Mitigate Hypersensitivity Reactions to Biologicals Induced by Anti-Drug Antibodies? by Alessandra Vultaggio, Margherita Perlato, Francesca Nencini, Emanuele Vivarelli, Enrico Maggi, Andrea Matucci

    Published 2021-11-01
    Get full text
    Article
  10. 10
    Asthma and Chronic Rhinosinusitis: How Similar Are They in Pathogenesis and Treatment Responses?

    Asthma and Chronic Rhinosinusitis: How Similar Are They in Pathogenesis and Treatment Responses? by Andrea Matucci, Susanna Bormioli, Francesca Nencini, Fabio Chiccoli, Emanuele Vivarelli, Enrico Maggi, Alessandra Vultaggio

    Published 2021-03-01
    Get full text
    Article
  11. 11
    Rapid clinical improvement of atopic dermatitis in an Omalizumab treated patient

    Rapid clinical improvement of atopic dermatitis in an Omalizumab treated patient by Susanna Bormioli, Andrea Matucci, Laura Dies, Francesca Nencini, Francesca Grosso, Enrico Maggi, Alessandra Vultaggio

    Published 2019-03-01
    Get full text
    Article
  12. 12
    Drug-specific Treg cells are induced during desensitization procedure for rituximab and tocilizumab in patients with anaphylaxis

    Drug-specific Treg cells are induced during desensitization procedure for rituximab and tocilizumab in patients with anaphylaxis by Alessandra Vultaggio, Francesca Nencini, Susanna Bormioli, Elena Silvestri, Laura Dies, Emanuele Vivarelli, Enrico Maggi, Andrea Matucci

    Published 2021-06-01
    Get full text
    Article
  13. 13
    The anti-inflammatory cytokine IL-37 improves the NK cell-mediated anti-tumor response

    The anti-inflammatory cytokine IL-37 improves the NK cell-mediated anti-tumor response by Nadine Landolina, Francesca Romana Mariotti, Andrea Pelosi, Valentina D’Oria, Tiziano Ingegnere, Claudia Alicata, Paola Vacca, Lorenzo Moretta, Enrico Maggi

    Published 2024-12-01
    Get full text
    Article
  14. 14
    Characterization of Human NK Cell-Derived Exosomes: Role of DNAM1 Receptor in Exosome-Mediated Cytotoxicity against Tumor

    Characterization of Human NK Cell-Derived Exosomes: Role of DNAM1 Receptor in Exosome-Mediated Cytotoxicity against Tumor by Anna Laura Di Pace, Nicola Tumino, Francesca Besi, Claudia Alicata, Libenzio Adrian Conti, Enrico Munari, Enrico Maggi, Paola Vacca, Lorenzo Moretta

    Published 2020-03-01
    Get full text
    Article
  15. 15
    Hapten-Specific Th17 Cells in the Peripheral Blood of β-Lactam-Induced AGEP

    Hapten-Specific Th17 Cells in the Peripheral Blood of β-Lactam-Induced AGEP by Lucia Filì, Elisa Cardilicchia, Maurizio G Severino, Sergio Testi, Andrea Matucci, Alessandra Vultaggio, Milena Paglierani, Daniela Massi, Enrico Maggi, Paola Parronchi

    Published 2014-01-01
    Get full text
    Article
  16. 16
    Efficacy and Safety of Mepolizumab (Anti-Interleukin-5) Treatment in Gleich’s Syndrome

    Efficacy and Safety of Mepolizumab (Anti-Interleukin-5) Treatment in Gleich’s Syndrome by Andrea Matucci, Francesco Liotta, Emanuele Vivarelli, Laura Dies, Francesco Annunziato, Marie Pierre Piccinni, Francesca Nencini, Sara Pratesi, Enrico Maggi, Alessandra Vultaggio

    Published 2018-05-01
    Get full text
    Article
  17. 17
    Toll-like receptor 8 agonists improve NK-cell function primarily targeting CD56brightCD16− subset

    Toll-like receptor 8 agonists improve NK-cell function primarily targeting CD56brightCD16− subset by Enrico Maggi, Giovanni Scambia, Anna Fagotti, Lorenzo Moretta, Andrea Pelosi, Irene Veneziani, Valentina D'Oria, Claudia Alicata, Nadine Landolina, Biancamaria Ricci

    Published 2022-01-01
    Get full text
    Article
  18. 18
    Pediatric Tumors-Mediated Inhibitory Effect on NK Cells: The Case of Neuroblastoma and Wilms’ Tumors

    Pediatric Tumors-Mediated Inhibitory Effect on NK Cells: The Case of Neuroblastoma and Wilms’ Tumors by Andrea Pelosi, Piera Filomena Fiore, Sabina Di Matteo, Irene Veneziani, Ignazio Caruana, Stefan Ebert, Enrico Munari, Lorenzo Moretta, Enrico Maggi, Bruno Azzarone

    Published 2021-05-01
    Get full text
    Article
  19. 19
    Angiogenic T cell expansion correlates with severity of peripheral vascular damage in systemic sclerosis.

    Angiogenic T cell expansion correlates with severity of peripheral vascular damage in systemic sclerosis. by Mirko Manetti, Sara Pratesi, Eloisa Romano, Silvia Bellando-Randone, Irene Rosa, Serena Guiducci, Bianca Saveria Fioretto, Lidia Ibba-Manneschi, Enrico Maggi, Marco Matucci-Cerinic

    Published 2017-01-01
    Get full text
    Article
  20. 20
    IL-1R8 silencing improves the anti-tumor function of freshly isolated human NK cells

    IL-1R8 silencing improves the anti-tumor function of freshly isolated human NK cells by Enrico Maggi, Alberto Mantovani, Lorenzo Moretta, Francesca Romana Mariotti, Andrea Pelosi, Irene Veneziani, Claudia Alicata, Nadine Landolina, Biancamaria Ricci, Tiziano Ingegnere, Bruno Giuseppe Azzarone, Cecilia Garlanda

    Published 2022-03-01
    Get full text
    Article

Search Tools: